Causes, management approaches, and outcome of acute renal failure in children

Current Opinion in Pediatrics

Volumn 10, Issue 2, 1998, Pages 184-189

  Flynn, Joseph T ^a  

^a Pediatric Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; ATRIAL NATRIURETIC FACTOR; CALCIUM CARBONATE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; IMMUNOGLOBULIN; SODIUM DERIVATIVE; SOMATOMEDIN; TACROLIMUS;

ACUTE KIDNEY FAILURE; CHILD; DIALYSIS; DIET RESTRICTION; ESCHERICHIA COLI; FLUID THERAPY; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY TUBULE NECROSIS; MORBIDITY; MORTALITY; PEDIATRICS; PRIORITY JOURNAL; REVIEW; URINE VOLUME;

CHILD; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 0031804198     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199804000-00012     Document Type: Review

References (78)

1. Sehic A, Chesney RW: Acute renal failure: Diagnosis. Pediatr Rev 1995, 16:101-106.
2. Kandoth PW, Agarwal GJ, Dharnidha VR: Acute renal failure in children requiring dialysis therapy. Indian Pediatr 1994, 31:305-309.
3. Arora P, Kher V, Rai PK, Singhal MK, Galati S, Gupta A: Prognosis of acute renal failure in children: A multivariate analysis. Pediatr Nephrol 1997, 11:153-155. An interesting look at acute renal failure in a developing country, including causes, management, and outcome.
4. Bunchman TE, Smoyer WE, Valentini RP, Kershaw DB, Gregory MJ, Sedman AB: Modality and mortality in pediatric renal replacement therapy [abstract]. J Am Soc Nephrol 1994, 5:436.
5. Werner HA, Wensley DF, Lirenmen DS, LeBlanc JG: Peritoneal dialysis in children after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1997, 113:64-68.
6. Binswanger U: Acute renal failure: Changing causes? Kidney Blood Press Res 1997, 20:163.
7. Liano F, Pascual J, and the Madrid Acute Renal Failure Study Group: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kid Int 1996, 50:811-818. Outstanding prospective study of ARF in an urban setting, highlighting the changing pattern of ARF faced by the practicing nephrologist.
8. Baretti P, Soares VA: Acute renal failure: Clinical outcomes and causes of death. Ren Fail 1997, 19:253-257.
9. Roifman CM: Use of intravenous immune globulin in the therapy of children with rheumatological diseases. J Clin Immunol 1995, 15:42S-51S.
10. Hemming VG, Prince GA, Groothuis JR, Siber GR: Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol 1995, 8:22-33.
11. Stiehm ER: Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J 1997, 16:696-707.
12. Michail S, Nakopoulou L, Stavrianopoulos I, Stamatiadis D, Avdikou K, Vaiopoulos G, Stathakis C: Acute renal failure associated with immunoglobulin administration. Nephrol Dial Transplant 1997, 12:1497-1499.
13. Ahsan N, Wiegand LA, Abendroth CS, Manning EC: Acute renal failure following immunoglobulin therapy. Am J Nephrol 1996, 16:532-536.
14. Mann JF, Goerig M, Brune K, Luft FC: Ibuprofen as an over-the-counter drug: Is there a risk for renal injury? Clin Nephrol 1993, 39:1-6.
15. McIntire SC, Rubenstein RC, Gartner JC Jr., Gilboa N, Ellis D: Acute flank pain and reversible renal dysfunction associated with nonsteroidal anti-inflammatory drug use. Pediatrics 1993, 92:459-460.
16. Kim J, Gazanan M, Verjee Z, Johnson D: Acute renal insufficiency in ibuprofen overdose. Pediatr Emerg Care 1995, 11:107-108.
17. Primack WA, Rahman SM, Pullman J: Acute renal failure associated with amoxicillin and ibuprofen in an 11 year-old boy. Pediatr Nephrol 1997, 11:125-126.
18. Buck ML, Norwood VF: Ketorolac-induced acute renal failure in a previously healthy adolescent. Pediatrics 1996, 98:294-296.
19. Feldman HI, Kinman JL, Berlin JA, Hennessy S, Kimmel SE, Farrar J, Carson JL, Strom BL: Parenteral ketorolac: The risk for acute renal failure. Ann Intern Med 1997, 126:193-199.
20. Vachvanichsanong P, Patamasucon P, Malagon M, Moore ES: Acute renal failure in a child associated with acyclovir. Pediatr Nephrol 1995, 9:346-347.
21. Ahmad T, Simmonds M, McIver AG, McGraw ME: Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis. Pediatr Nephrol 1994, 8:489-491.
22. Wood EG, Bunchman TE, Lynch RE: Captopril-induced reversible acute renal failure in an infant with coarctation of the aorta. Pediatrics 1991, 88:816-818.
23. Krishna EV, Mehta AV, Subrahmanyam AB, Wattad AA: Acute renal failure associated with use of angiotensin converting enzyme inhibitor: A report of two children with Down's syndrome. J Tenn Med Assoc 1996, 89:5-7.
24. Platz KP, Muelle AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P: Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994, 58:170-178.
25. Weisbert LS, Allgren RL, Genter FC, Kurnik BR: Cause of acute tubular necrosis affects its prognosis. The Auriculin Anaritide Acute Renal Failure Study Group. Arch Intern Med 1997, 157:1833-1838.
26. Karmalina A, Petric M, Lim C, Fleming PC, Arbus G, Lior H: The association between idiopathic haemolytic-uraemic syndrome and infection by verotoxin-producing E. coli. J Infec Dis 1985, 151:775-782.
27. Gianviti A, Rosmini F, Caprioli A, Corona R, Matteucci RC, Principato F, Luzzi I, Rizzoni G and the Italian HUS Study Group: Haemolytic-uraemic syndrome in childhood: Surveillance and case-control studies in Italy. Pediatr Nephrol 1994, 8:705-709.
28. Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, Avner ED: Escherichia coli O157:H7-assoclated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr 1994, 125:519-526.
29. Mead PS, Finelli L, Lambertfair MA, Champ O, Townes J, Hutwagner L, Barrett T, Spitalny K, Mintz E: Risk factors for sporadic infection with Escherichia coli O157:H7. Arch Intern Med 1997, 157:204-208.
30. Centers for Disease Control and Prevention: Outbreak of Escherichia coli O157:H7 infections associated with drinking unpasteurized commercial apple juice: British Columbia, California, Colorado, and Washington, October 1996. MMWR 1996, 45:975.
31. Mshar PA, Dembek ZF, Cartter ML, Hadler JL, Fiorentino TR, Marcus RA, Mcguire J, Shiffrin MA, Lewis A, Feuss J, et al.: Outbreaks of Escherichia coli O157:H7 infection and cryptosporidiosis with drinking unpasteurized apple cider: Connecticut and New York, October 1996. MMWR 1997, 46:5-8.
32. Keene WE, Sazie E, Kok J, Rice DH, Hancock DD, Balan VK, Zhao T, Doyle MP: An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 1997, 277:1229-1231.
33. Tarr PI, Fouser LS, Stapleton AE, Wilson RA, Kim HH, Vary JC, Clausen CR: Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with shiga-toxin producing Escherichia coli O103:H2. N Engl J Med 1996, 335:635-638.
34. Banatvala N, Debeukelaer MM, Griffin PM, Barrett TJ, Greene KD, Green JH, Wells JG: Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: A family outbreak. Pediatr Infect Dis J 1996, 15:1008-1011.
35. Boudailliez B, Berquin P, Marianikurkdjian P, Ilef DD, Cuvelier B, Capek I, Tribout B, Bingen E, Piussan C: Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr Nephrol 1997, 11:36-39. This article demonstrates that serotypes of E. coli other than O157:H7 are capable of causing HUS and can be transmitted easily by person-to-person contact, leading to "mini epidemics" of typical HUS within families.
36. Rondeau R, Peraldi MN: Escherichia coli and the hemolytic-uremic syndrome. N Engl J Med 1996, 335:660-662.
37. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI: Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia colt O157:H7 infections. Pediatrics 1997, 100:http://www.pediatrics.org/cgi/content/full/100/1/e12. This cohort study attempts to answer from an epidemiologic perspective why some children develop full-blown HUS following infection by E. coli and others do not. It lays the groundwork for future studies aimed at prevention of HUS.
38. Karlowicz MG, Adelman RD: Acute renal failure in the neonate. Clin Perinatol 1992, 19:139-158.
39. Airede A, Bello M, Weerasinghe HD: Acute renal failure in the newborn: Incidence and outcome. J Paediatr Child Health 1997, 33:246-249.
40. Karlowicz MG, Adelman RD: Nonoliguric and oliguric acute renal failure in asphyxiated term neonates. Pediatr Nephrol 1995, 9:718-722.
41. Vanpee M, Ergander U, Herin P, Apecia A: Renal function in sick, very low-birth-weight infants. Acta Paediatr 1993, 82:714-718.
42. Pryde PG, Sedman AB, Nugent CE, Barr M: Anglotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993, 3:1575-1582.
43. Lavoratti G, Seracini D, Piorini P, Cocchi C, Materassi M, Donzelli G, Pela I: Neonatal anuria by ACE inhibitors during pregnancy. Nephron 1997, 76:235-236.
44. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J: Renal failure in the neonate associated with in utero exposure to non-steroldal anti-inflammatory agents. Pediatr Nephrol 1994, 8:700-704.
45. Sehic A, Chesney RW: Acute renal failure: Therapy. Pediatr Rev 1995, 16:137-141.
46. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996, 334:1448-1460. A cogent and thorough review of ARF, with emphasis on pathophysiology.
47. Mendley SR, Langman CB: Acute renal failure in the pediatric patient. Ad Ren Replace Ther 1997, 4(Suppl 1):93-101. An excellent review of the practical aspects of ARF in children.
48. Schulman SL, Kaplan BS: Management of patients with hemolytic uremic syndrome demonstrating severe azotemla but not anuria. Pediatr Nephrol 1996, 10:671-674.
49. Szerlip HM: Renal-dose dopamine: Fact and fiction. Ann Intern Med 1991, 115:153-154.
50. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM: Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 1996, 101:49-53. One of the most important studies to address this topic in recent memory. The investigators demonstrate in a large, prospective study that "renal-dose" dopamine had no beneficial effect in reducing the need for dialysis or preventing death.
51. Harper L, Savage CO: The use of dopamine in acute renal failure. Clin Nephrol 1997, 47:347-349.
52. Bonde J, Lauritsen HK, Stenberg M, Kamp-Jensen M, Olsen NV: Low-dose dopamine in surgical and intensive care unit patients. Acta Anaesthesiol Scand 1996, 40:326-330.
53. Sponsel H, Conger JD: Is parenteral nutrition therapy of value in acute renal failure patients? Am J Kid Dis 1995, 25:96-102.
54. Riella MC: Nutrition in acute renal failure. Ren Fail 1997, 19:237-252.
55. Ikizler TA, Himmelfarb J: Nutrition in acute renal failure patients. Adv Ren Replace Ther 1997, 4(Suppl 1):54-63.
56. Bunchman TE, Donckerwolcke R: Continuous arterial-venous diahemofiltration and continuous veno-venous diahemofiltration in infants and children. Pediatr Nephrol 1994, 8:96-102.
57. Parekh RS, Bunchman TE: Dialysis support in the pediatric intensive care unit. Adv Ren Replace Ther 1996, 3:326-336.
58. Ellis EN, Pearson D, Belsha CW, Berry PL: Use of pump-assisted hemofiltration in children with acute renal failure. Pediatr Nephrol 1997, 11:196-200.
59. Clark WR, Mueller BA, Kraus MA, Macias WL: Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997, 8:804-812.
60. Misset B, Timsit JF, Chevret S, Renaud B, Tamion F, Carlet J: A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 1996, 22:742-746.
61. Maxvold NJ, Smoyer WE, Gardner JJ, Bunchman TE: Management of acute renal failure in the pediatric patient: Hemofiltration vs. Hemodialysis. Am J Kid Dis 1997, 30(Suppl 4):S84-S88. One of the first studies to compare continuous hemofiltration with a conventional dialysis modality in children.
62. Wong W, McCall E, Anderson B, Segedin E, Morris M: Acute renal failure in the paediatric intensive care unit. N Z Med J 1996, 109:459-461.
63. Kohli HS, Arora P, Kher V, Gupta A, Sharma RK, Bhaumik SK: Daily peritoneal dialysis using a surgically placed Tenckhoff catheter for acute renal failure in children. Ren Fail 1995, 17:51-56.
64. Bunchman TE: Acute peritoneal dialysis access in infant renal failure. Perit Dial Int 1996, 16:S509-S511.
65. Kohli HS, Barkataky A, Kumar RS, Sud K, Jha V, Gupta KL, Sakhuja V: Peritoneal dialysis for acute renal failure in infants: A comparison of three types of peritoneal access. Ren Fail 1997, 19:165-170.
66. Acharya UT, Singla PN, Singh RG, Usha Mishra OP: Outcome of dialysed patients with acute renal failure. Indian Pediatr 1996, 33:387-390. Another look at ARF in the developing world.
67. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR: Childhood hemolytic uremic syndrome in Argentina: Long-term follow-up and prognostic features. Pediatr Nephrol 1997, 11:156-160.
68. Siegler RL, Pavia AT, Cook JB: Hemolytic-uremic syndrome in adolescents. Arch Pediatr Adolesc Med 1997, 151:165-169. An intriguing look at a subpopulation of children with HUS long thought to be at higher risk of poor outcomes. Surprisingly, outcomes in teenagers were similar to those in younger children.
69. Neuhaus TJ, Calonder S, Leumann EP: Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Child 1997, 76:518-521.
70. Keiles A, Van Dyck M, Proesmans W: Childhood haemolytic uraemic syndrome: Long-term outcome and prognostic features. Eur J Pediatr 1994, 153:38-42.
71. Siegler RL, Pavia AT, Christofferson RD, Milligan MK: A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994, 94:35-40.
72. Georgaki-Angelaki HN, Steed DB, Chantler C, Haycock G: Renal function following acute renal failure in childhood: A long-term follow-up study. Kid Int 1989, 35:84-89.
73. Verbeke M, VanDeVoorde J, Lameire N: Prevention of experimental acute tubular necrosis: Current clinical applications and perspectives. Adv Nephrol Necker Hosp 1996, 25:177-216.
74. Garcia RE: Therapeutic strategies in the prevention of acute renal failure. Ren Fail 1997, 19:231-235.
75. Wang S, Hirschberg R: Role of growth factors in acute renal failure. Nephrol Dial Transplant 1997, 12:1560-1563.
76. Harris RC: Growth factors and cytokines in acute renal failure. Adv Ren Replace Ther 1997, 4(Suppl 1):43-53.
77. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. N Engl J Med 1997, 336:828-834. Represents one of the first clinical applications of previously experimental approaches to the treatment of ARF.
78. Hirschberg R: Biologically active peptides in acute renal failure: Recent clinical trials. Nephrol Dial Transplant 1997, 12:1563-1566.